ClinicalTrials.Veeva

Menu

Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly (ProMO)

W

Wageningen University

Status

Unknown

Conditions

Malnutrition
Muscle Health

Treatments

Dietary Supplement: ONS

Study type

Interventional

Funder types

Other

Identifiers

NCT02683720
NL56873.081.16

Details and patient eligibility

About

ProMO aims to investigate the effectiveness of a newly developed ONS in increasing body weight, muscle mass and function in malnourished elderly compared to standard care.

Enrollment

82 estimated patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 65+
  • at risk of malnutrition/ malnourished

Exclusion criteria

  • • Mental status that is incompatible with the proper conduct of the study

    • Illness of such severity that life expectancy is considered to be less than 12 months
    • Use of diabetes medication (e.g. insulin, methformin)
    • Use of an oral nutritional supplement in the previous three months
    • Participating in any regular exercise training program (≥2h/w)
    • Renal insufficiency (eGFR <30 mL/min/1.73 m2)
    • Unstable organ failure or organ failure necessitating a special diet
    • Chronic corticosteroids use
    • Recent (previous 2 months) use of antibiotics
    • Recent (previous 3 months) change in habitual medication use (e.g statins and thyroxin)
    • Recent blood donation (<1 month prior to Day 01 of the study)
    • Not willing or afraid to give blood during the study
    • Allergic or sensitive for milk proteins
    • Reported vegan or macrobiotic life-style
    • Drug and/or alcohol abuse (current consumption of more than 21 alcoholic drinks per week)
    • Individual unable to give informed consent
    • Current participation in other research from the Division of Human Nutrition
    • Not having a general practitioner
    • Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

82 participants in 2 patient groups

ONS1
Experimental group
Description:
new product
Treatment:
Dietary Supplement: ONS
ONS2
Active Comparator group
Description:
usual care
Treatment:
Dietary Supplement: ONS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems